RxDoctor Payments Data

Kara Gerbino

Adult Health · New York, NYNPI 1164942330

Payments from drug & device makers

$13,010in general payments, 2019–2025

Across 133 payments — averaging $97.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$5K
  • Abbott$2K
  • United Therapeutics Corporation$2K
  • AstraZeneca$735
  • Scpharmaceuticals Inc.$522
  • Boehringer Ingelheim$452
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$3,78329%
  • Travel & lodging$3,38526%
  • Food & beverage$5,74344%
  • Education$991%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,010 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
UptraviSelexipag127$3,065,449
AdempasRiociguat124$1,652,206
Tyvaso DpiTreprostinil68$1,553,682
OpsumitMacitentan69$957,184
Orenitram ErTreprostinil Diolamine58$877,533
Ambrisentan111$554,801
Tadalafil78$122,999
EntrestoSacubitril/Valsartan63$69,054
JardianceEmpagliflozin54$58,056
EliquisApixaban36$29,731
FarxigaDapagliflozin Propanediol15$19,216
Sildenafil Citrate18$1,966
Bumetanide20$608
Torsemide13$440
Furosemide117$440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit$4,917$4,022,633196 claims
BayerAdempas$450$1,652,206124 claims
NovartisEntresto$137$69,05463 claims
Boehringer IngelheimJardiance$452$58,05654 claims
PfizerEliquis$89$29,73136 claims
AstraZenecaFarxiga$735$19,21615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.

Other adult health in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →